New normal: two aspects of adipose tissue in COVID-19—treat and threat?

References

• Morestin H. Quelques cas de greffes graisseuse appliquees aIa chirurgie reparatrice. Bull Mem Soc Chir (Paris). 1915;41:1631.
   Google Scholar
• Gentile P, Calabrese C, De Angelis B, et al. Impact of the different preparation methods to obtain human adipose-derived stromal vascular fraction cells (AD-SVFs) and human adipose-derived mesenchymal stem cells (AD-MSCs): enzymatic digestion versus mechanical centrifugation. Int J Mol Sci. 2019 Nov 2;20(21):5471. Published.
   PubMed Web of Science ®Google Scholar
• Oon CJ, Hobbs JR. Clinical applications of the continuous flow blood separator machine. Clin Exp Immunol. 1975;20(1):1–16.
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–228.
   PubMedGoogle Scholar
• Cervelli V, Bocchini I, Di Pasquali C, et al. P.R.L. platelet rich lipotransfert: our experience and current state of art in the combined use of fat and PRP. Biomed Res Int. 2013;2013:434191.
   PubMed Web of Science ®Google Scholar
• Gentile P, De Angelis B, Pasin M, et al. Adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical evaluation for cell-based therapies in patients with scars on the face. J Craniofac Surg. 2014;25(1):267–272.
   PubMed Web of Science ®Google Scholar
• Tonnard P, Verpaele A, Peeters G, et al. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;132(4):1017–1026.
   PubMed Web of Science ®Google Scholar
• Gentile P, Scioli MG, Bielli A, et al. Comparing different nanofat procedures on scars: role of the stromal vascular fraction and its clinical implications [published correction appears in Regen Med. 2018 Jan;13(1):117]. Regen Med. 2017;12(8):939–952.
   PubMed Web of Science ®Google Scholar
• Rohrich RJ, Wan D. Making sense of stem cells and fat grafting in plastic surgery: the hype, evidence, and evolving U.S. food and drug administration regulations. Plast Reconstr Surg. 2019;143:417–424.
   Web of Science ®Google Scholar
• Sesé B, Sanmartín JM, Ortega B, et al. Nanofat cell aggregates: a nearly constitutive stromal cell inoculum for regenerative site-specific therapies. Plast Reconstr Surg. 2019;144(5):1079–1088.
   PubMed Web of Science ®Google Scholar
• Copcu HE, Oztan S. New mechanical fat separation technique: ARAT and MEST. Aesthetic Surg J Open Forum. 2020;ojaa035. DOI:10.1093/asjof/ojaa035.
   Google Scholar
• Ghiasloo M, Lobato RC, Díaz JM, et al. Expanding clinical indications of mechanically isolated stromal vascular fraction: a systematic review [published online ahead of print, 2020 May 2]. Aesthet Surg J. 2020;sjaa111. DOI:10.1093/asj/sjaa111
   Web of Science ®Google Scholar
• Gentile P, Casella D, Palma E, et al. Engineered fat graft enhanced with adipose-derived stromal vascular fraction cells for regenerative medicine: clinical, histological and instrumental evaluation in breast reconstruction. J Clin Med. 2019 Apr 12;8(4):504. Published.
   PubMed Web of Science ®Google Scholar
• Gentile P, Piccinno MS, Calabrese C. Characteristics and potentiality of human adipose-derived stem cells (hASCs) obtained from enzymatic digestion of fat graft. Cells. 2019 Mar 25;8(3):282. Published.
   PubMed Web of Science ®Google Scholar
• Andia I, Maffulli N, Burgos-Alonso N. Stromal vascular fraction technologies and clinical applications. Expert Opin Biol Ther. 2019;19(12):1289–1305.
   PubMed Web of Science ®Google Scholar
• Gentile P, Sterodimas A. Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia [published online ahead of print, 2020 Apr 29]. Expert Opin Biol Ther. 2020;1‐6. DOI:10.1080/14712598.2020.1761322
   Web of Science ®Google Scholar
• Gan R, Rosoman NP, Henshaw DJE, et al. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease [published online ahead of print, 2020 Jun 23]. Med Hypotheses. 2020;144:110024.
   PubMed Web of Science ®Google Scholar
• Gentile P, Garcovich S. Concise review: adipose-derived stem cells (ASCs) and adipocyte-secreted exosomal microRNA (A-SE-miR) modulate cancer growth and promote wound repair. J Clin Med. 2019 Jun 15;8(6):855. Published.
   PubMed Web of Science ®Google Scholar
• Schildberg FA. Donneberg VS Stromal cells in health and disease. Cytometry. 2018;93(9):871–875.
   PubMedGoogle Scholar
• Bourin P, Bunnell BA, Casteilla L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the international federation for adipose therapeutics and science (IFATS) and the international society for cellular therapy (ISCT). Cytotherapy. 2013;15(6):641–648.
   PubMed Web of Science ®Google Scholar
• Ullah M, Liu DD, Thakor AS. Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience. 2019;15:421–438.
   PubMed Web of Science ®Google Scholar
• Bari E, Ferrarotti I, Saracino L, et al. Mesenchymal stromal cell secretome for severe COVID-19 infections: premises for the therapeutic use. Cells. 2020;9(4):E924.
   PubMed Web of Science ®Google Scholar
• Al-Ghadban S, Bunnell BA. Adipose tissue-derived stem cells: immunomodulatory effects and therapeutic potential. Physiology (Bethesda). 2020;35(2):125–133.
   PubMed Web of Science ®Google Scholar
• Fukui E, Funaki S, Kimura K, et al. Adipose tissue-derived stem cells have the ability to differentiate into alveolar epithelial cells and ameliorate lung injury caused by elastase-induced emphysema in mice. Stem Cells Int. 2019 Jun 10;2019:5179172. DOI:10.1155/2019/5179172.
   Web of Science ®Google Scholar
• Silva JD, Lopes-Pacheco M, Paz A, et al. Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome. Crit Care Med. 2018;46(2):e132–e140.
   PubMed Web of Science ®Google Scholar
• Sun Z, Li F, Zhou X, et al. Stem cell therapies for chronic obstructive pulmonary disease: current status of pre-clinical studies and clinical trials. J Thorac Dis. 2018;10(2):1084–1098.
   PubMed Web of Science ®Google Scholar
• Zimmerlin L, Rubin JP, Pfeifer ME, et al. Human adipose stromal vascular cell delivery in a fibrin spray. Cytotherapy. 2013;15(1):102–108.
   PubMed Web of Science ®Google Scholar
• Lee JW, Gupta N, Serikov V, et al. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther. 2009;9(10):1259–1270.
   PubMed Web of Science ®Google Scholar
• Urbanek K, De Angelis A, Spaziano G, et al. Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model. PLoS One. 2016 Jul 19;11(7):e0158746. Published.
   PubMed Web of Science ®Google Scholar
• Chang YS, Ahn SY, Yoo HS, et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014;164(5):966–972.e6.
   PubMed Web of Science ®Google Scholar
• Gentile P, Sterodimas A, Pizzicannella, et al. Research progress on mesenchymal stem cells (MSCs), adipose-derived mesenchymal stem cells (AD- JMSCs), drugs, and vaccines in inhibiting COVID-19 disease[J]. Aging Dis. 2020. DOI:10.14336/AD.2020.0711.
   Web of Science ®Google Scholar
• Ryan PM, Caplice NM. Is adipose tissue a reservoir for viral spread, immune activation and cytokine amplification in COVID-19. Obesity (Silver Spring). 2020;28:1191–1194. Advance online publication.
   Web of Science ®Google Scholar
• Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity. 2008;28(4):468–476.
   PubMed Web of Science ®Google Scholar
• Khoury M, Cuenca J, Cruz FF, et al. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur Respir J. 2020;55:2000858. Advance online publication.
   PubMed Web of Science ®Google Scholar
• Lopes-Pacheco M, Robba C, Rocco P, et al. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome. Cell Biol Toxicol. 2020;36(1):83–102.
   PubMed Web of Science ®Google Scholar
• Taghavi-Farahabadi M, Mahmoudi M, Hashemi SM, et al. Evaluation of the effects of mesenchymal stem cells on neutrophils isolated from severe congenital neutropenia patients. Int Immunopharmacol. 2020;83:106463.
   PubMed Web of Science ®Google Scholar
• Garg RK, Rennert RC, Duscher D, et al. Capillary force seeding of hydrogels for adipose-derived stem cell delivery in wounds. Stem Cells Transl Med. 2014;3(9):1079–1089.
   PubMed Web of Science ®Google Scholar
• Shetty AK. Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)- induced pneumonia. Aging Dis. 2020;11(2):462–464.
   PubMed Web of Science ®Google Scholar
• Hoogduijn MJ, Lombardo E. Mesenchymal stromal cells anno 2019: dawn of the therapeutic era? Concise review. Stem Cells Transl Med. 2019;8(11):1126–1134.
   PubMed Web of Science ®Google Scholar
• Gentile P, Sterodimas A. Adipose stem cells (ASCs) and stromal vascular fraction (SVF) as a potential therapy in combating (COVID-19)-disease. Aging Dis. 2020 May 9;11(3):465–469. Published.
   PubMed Web of Science ®Google Scholar
• Ji F, Li L, Li Z, et al. Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019. Stem Cells Transl Med. 2020;9: 813–814. Advance online publication.
   Web of Science ®Google Scholar
• Shetty R, Ghosh A, Honavar S, et al. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: present and future. Indian J Ophthalmol. 2020;68(5):693–702.
   PubMed Web of Science ®Google Scholar
• Jia X, Yin C, Lu S, et al. Two things about COVID-19 might need attention. Preprints. 2020:2020020315. DOI:10.20944/preprints202002.0315.v1).
   Google Scholar
• Hoffmann, M., Schroeder, S., Kleine-Weber, H., et al. Nafamostat mesylate blocks activation of SARS-CoV-2: New treatment option for COVID-19. Antimicrobial agents and chemotherapy. 2020 May;64(6):1–3. DOI:10.1128/AAC.00754-20
   Google Scholar
• Slamkova M, Zorad S, Krskova K. Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity. Endocr Regul. 2016;50(4):229–240.
   PubMedGoogle Scholar
• Américo ALV, Muller CR, Vecchiatto B, et al. Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue. PLoS One. 2019 Apr 25;14(4):e0215896. Published.
   PubMed Web of Science ®Google Scholar
• Frantz EDC, Prodel E, Braz ID, et al. Modulation of the renin-angiotensin system in white adipose tissue and skeletal muscle: focus on exercise training. Clin Sci (Lond). 2018 Jul 23;132(14):1487‐1507. Published.
   PubMed Web of Science ®Google Scholar
• Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15(4):277‐287.
   PubMed Web of Science ®Google Scholar
• Patel VB, Basu R, Oudit GY. ACE2/Ang 1–7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity. Adipocyte. 2016 Jan 6;5(3):306‐311. Published.
   PubMed Web of Science ®Google Scholar
• Pahlavani M, Kalupahana NS, Ramalingam L, et al. Regulation and functions of the renin-angiotensin system in white and brown adipose tissue. Compr Physiol. 2017 Sep 12;7(4):1137‐1150. Published.
   PubMed Web of Science ®Google Scholar